|
|
 |
|
Viewing report
|
|
 |
 |
Cancer Drug Delivery: Managing Cancer Patients Beyond Oral Formulation
Datamonitor, Oct 2001
Oral and injectable formulations are the two main drug delivery systems used for anti-cancer drug. However, each system is hampered by problems of its own and there is yet no answer to the problem of delivering drug with convenience and increased efficacy. The high level of interest in drug delivery technology development will, to a certain extent, close the gap in unmet need, yet it will be several years before any breakthrough is made in improving anti-cancer drug administration. This brief provides an overview the current role of drug delivery technology in the cancer market, looking at the current systems and products incorporating these technologies. This is followed by detailed analyses of these drug delivery markets in terms of their strengths and weaknesses, opportunities and threats. Finally, the future of drug delivery and its implications for the cancer therapeutic market will be examined in details.
Customers who bought this item also bought
Drug Delivery in Cancer - Technologies, Markets and Companies
Transdermal Drug Delivery - Technologies, Markets, and Companies
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
Nanobiotechnology Applications, Markets and Companies
Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
RNAi - Technologies, Markets and Companies
Personalized Medicine - Scientific and Commercial Aspects
Pulmonary Drug Delivery Technologies - Global Strategic Business Report
Nanoparticle Drug Delivery Market Report
Targeted Drug Delivery Technologies: Players, products & prospects to 2015
The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition
Anticancer Therapeutics
|
 |
|
|